Technical analysis of CAMP4 Therapeutics Corporation (CAMP): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Price Performance
| 1 month | -21.22% |
| 3 months | -6.54% |
| Year-to-date | -37.03% |
| 1 year | +49.03% |
52-Week Range
| 52-week High | $7.75 |
| 52-week Low | $2.20 |
| Avg Volume (90d) | 227K |
Technical Indicators
| SMA 50 | $4.11 |
| SMA 200 | $4.51 |
| Beta | 0.41 |
| 30-day Volatility (annualised) | 99.9% |
| Price vs SMA 50 | -6.0% |
| Price vs SMA 200 | -14.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $4.16 | |
| 2025-11 | $3.80 | -8.7% |
| 2025-12 | $6.13 | +61.3% |
| 2026-01 | $3.70 | -39.6% |
| 2026-02 | $4.49 | +21.4% |
| 2026-03 | $4.41 | -1.8% |
| 2026-04 | $4.17 | -5.4% |
| 2026-05 | $4.39 | +5.3% |
| 2026-06 | $4.37 | -0.5% |
| 2026-07 | $3.45 | -21.1% |
| 2026-08 | $3.96 | +14.8% |
| 2026-09 | $3.86 | -2.5% |
Price
| Price | $3.86 |
| Market Cap | $82M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -362.08 |
| EV / EBITDA | -0.12 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -3.42 |
| Current Ratio | 4.70 |